4 Public sector jobs in Wales
Disability Confident
Remote working
Location
- UK
- Wales (4)
- Cardiff County (2)
- Denbighshire (1)
- Neath Port Talbot (1)
Posting date
Category
Contract type
Hours
- Full time (4)
Sign in now to create an email alert and receive the latest jobs for this search straight in your mailbox
Sign inDiscipline & Grievance Officer
- 12 April 2024
- Hays Specialist Recruitment - St Asaph, Denbighshire, LL17 0JJ
- £40,000.0 to £43,400.0 per year
- £40,400 - £43,400 DOE
- Contract
- Full time
Excellent opportunity for a strong HR/ER Advisor to join a close-knit HR team in a longstanding, public sector organisation. Within your new role as Discipline & Grievance Officer, you will report into the Head of HR and be the lead officer for the management ...
Afan Local Cluster Collaborative Lead
- 24 April 2024
- NHS Jobs - Neath Port Talbot, SA12 7BX
- £71,473.00 to £82,355.00 per hour
- £71473.00 - £82355.00 a session
- Permanent
- Full time
Work closely with the Clinical Director for Primary Care & Community Services, Associate Service Group Director, Head of Cluster Development and Planning, the Head of Primary Care, Cluster Development Manager, the Primary, Community and Therapies Service ...
Clinical Senior Lecturer/Reader/Prof in Haematology and Cell Therapy
- 15 April 2024
- NHS Jobs - Cardiff, CF14 4XN
- £91,722.00 to £119,079.00 per year
- £91722.00 - £119079.00 a year
- Permanent
- Full time
The appointee will work closely with haemato-oncology colleagues in the Early Phase Clinical Trials Team and the Bone Marrow Transplant Team (BMT), solid cancer colleagues at Cardiff and Vale UHB (C&V UHB) and Velindre University NHS Trust, and scientists ...
Clinical Senior Lecturer in Immuno-Oncology
- 27 March 2024
- NHS Jobs - Cardiff, CF14 4XN
- £91,722.00 to £119,079.00 per year
- £91722.00 - £119079.00 a year
- Contract
- Full time
Main Duties and Responsibilities Research To pursue research in novel immunotherapies and / or building understanding of immunotherapy mechanisms Clinical oncologists will additionally be expected to pursue research in immunotherapy/radiotherapy interactions ...
- 1